ventilator associated pneumonia. Pneumonia in bacterial diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: The first group will receive 5 ml chlorhexidine 0.2% (product of Behsa pharmaceutical company) as mouthwash three times per day in a mucoadhesive form from Carbomer
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age between 20 to 50 years Admission less than 24 hours in intensive care unit Intubated patient Satisfaction of patients' families
Exclusion criteria
Exclusion criteria: contraindications to any cause to enteral feeding pneumonia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of polymer in volume. Timepoint: At the beginning of experiment. Method of measurement: By weighing.;The amount of loading of cholorhexidine in gel. Timepoint: At the beginning of experiment. Method of measurement: By weighing.;The amount of release of cholorhexidine in gel. Timepoint: 1,2,3 and 4 hours after gel preparation. Method of measurement: Spectrophotometry.;Ventilator Associated Pneumonia. Timepoint: Third day, Sixth day, Ninth day, The twelfth day. Method of measurement: Clinical Pulmonary Infection Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality rate during hospitalization in Intensive Care Unit. Timepoint: End of the study. Method of measurement: Records.;Connection to ventilator days. Timepoint: End of the study. Method of measurement: Records.;Length of Intensive Care Unit stay. Timepoint: End of the study. Method of measurement: Records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarshad Khodami
Zanjan University of Medical Sciences
Outcome results
None listed